Of the three females with PPP, two developed subsequent central precocious puberty and were treated with GnRH (LHRH) analogs, while the remaining patient, who exhibited only PPP, was initially treated with aromatase inhibitors followed by estrogen receptor antagonists. Here, CYP19A1 is linked to precocious puberty.